Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022
Big Molecule Watch
SEPTEMBER 15, 2023
healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs, per the AAM’s report. billion for patients in 2022. Notably, the U.S. healthcare spending.
Let's personalize your content